1 |
Nadide
| - | 0件: | - | - | - |
2 |
Niacinamide
| 1件: Nicotinamide Nicotinamide | 4件: Ginseng Ginseng; Multivitamin; Niacinamide; NICOTINAMIDE; | - | - | 11件: 2 2, 5, 6, 13, 18, 49, 65, 67, 107, 162, 191 |
3 |
Niacin
| 1件: Niacin Niacin | 2件: Niacin Niacin; Nicotinic acid; | - | - | 4件: 6 6, 78, 79, 265 |
4 |
Nitric oxide
| 1件: Nitric Oxide Nitric Oxide | 3件: INOmax INOmax; Nitric Oxide; Nitrosyl; | - | - | 16件: 6 6, 13, 46, 58, 85, 86, 96, 97, 98, 210, 222, 226, 251, 294, 299, 321 |
5 |
Noradrenaline
| 1件: Norepinephrine Norepinephrine | 1件: Norepinephrine Norepinephrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 22 22 |
6 |
Nitrogen
| 1件: Nitrogen Nitrogen | 1件: Nitrogen Nitrogen; | - | - | 6件: 5 5, 6, 17, 171, 211, 299 |
7 |
Nitrous oxide
| 1件: Nitrous oxide Nitrous oxide | 1件: Nitrous Oxide Nitrous Oxide; | - | - | 1件: 34 34 |
8 |
Naproxen
| 1件: Naproxen Naproxen | 5件: Naprosyn Naprosyn; NAPROXEN; Naproxen oral suspension; NAPROXEN SODIUM; Propanoic acid; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 107, 271 |
9 |
Norethindrone
| 1件: Norethisterone Norethisterone | 3件: Norethindrone Norethindrone; Ortho-novum; Ortho-Novum 777; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 |
10 |
Nalidixic acid
| - | 0件: | - | - | - |
11 |
Nystatin
| - | 0件: | - | - | - |
12 |
Norfloxacin
| - | 0件: | - | - | - |
13 |
Nabumetone
| - | 0件: | - | - | - |
14 |
Nadolol
| 1件: Nadolol Nadolol | 1件: Nadolol Nadolol; | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
15 |
Nevirapine
| 1件: Nevirapine Nevirapine | 1件: Nevirapine Nevirapine; | - | - | 1件: 265 265 |
16 |
Niclosamide
| 1件: Niclosamide Niclosamide | 1件: Niclosamide Niclosamide; | - | - | 2件: 46 46, 97 |
17 |
Nifedipine
| 1件: Nifedipine Nifedipine | 1件: Nifedipine Nifedipine; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 50 50, 81 |
18 |
Nimodipine
| - | 0件: | - | - | - |
19 |
Nitrofurantoin
| 1件: Nitrofurantoin Nitrofurantoin | 1件: Nitrofurantoin Nitrofurantoin; | - | - | 1件: 13 13 |
20 |
Nizatidine
| - | 0件: | - | - | - |
21 |
Nitroglycerin
| 1件: Nitroglycerin Nitroglycerin | 2件: Nitroglycerin Nitroglycerin; Nitroglycerine; | - | - | 2件: 46 46, 51 |
22 |
Nedocromil sodium
| - | 0件: | - | - | - |
23 |
Nitrazepam
| - | 0件: | - | - | - |
24 |
Nicardipine hydrochloride
| 1件: Nicardipine Nicardipine | 1件: Nicardipine Nicardipine; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 70 70, 86 |
25 |
Nisoldipine
| - | 0件: | - | - | - |
26 |
Nitrendipine
| - | 0件: | - | - | - |
27 |
Naratriptan hydrochloride
| - | 0件: | - | - | - |
28 |
Nortriptyline hydrochloride
| 1件: Nortriptyline Nortriptyline | 2件: Nortriptyline Nortriptyline; Nortriptyline hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 |
29 |
Nefazodone hydrochloride
| - | 0件: | - | - | - |
30 |
Nifurtimox
| 1件: Nifurtimox Nifurtimox | 1件: Nifurtimox Nifurtimox; | - | - | 1件: 65 65 |
31 |
Nalbuphine hydrochloride
| 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine Nalbuphine; NALBUPHINE HYDROCHLORIDE; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
32 |
Nitrofurazone
| - | 0件: | - | - | - |
33 |
Netilmicin sulfate
| - | 0件: | - | - | - |
34 |
Naftifine hydrochloride
| - | 0件: | - | - | - |
35 |
Natamycin
| - | 0件: | - | - | - |
36 |
Nelfinavir mesylate
| 1件: Nelfinavir Nelfinavir | 1件: Nelfinavir Nelfinavir; | - | - | 3件: 49 49, 265, 331 |
37 |
Nafcillin sodium
| - | 0件: | - | - | - |
38 |
Norethindrone acetate
| 1件: Norethisterone Norethisterone | 3件: Norethindrone Norethindrone; Ortho-novum; Ortho-Novum 777; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 |
39 |
Norgestrel
| - | 0件: | - | - | - |
40 |
Nandrolone decanoate
| 1件: Nandrolone decanoate Nandrolone decanoate | 1件: Nandrolone Decanoate Nandrolone Decanoate; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 60 60, 85 |
41 |
Nandrolone phenpropionate
| - | 0件: | - | - | - |
42 |
Nilutamide
| - | 0件: | - | - | - |
43 |
Nafarelin acetate
| - | 0件: | - | - | - |
44 |
Noscapine
| - | 0件: | - | - | - |
45 |
Nimesulide
| 1件: Nimesulide Nimesulide | 1件: Nimesulide Nimesulide; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
46 |
Nifuratel
| - | 0件: | - | - | - |
47 |
Nateglinide
| - | 0件: | - | - | - |
48 |
Nadifloxacin
| - | 0件: | - | - | - |
49 |
Nicergoline
| - | 0件: | - | - | - |
50 |
Naloxone hydrochloride
| 1件: Naloxone Naloxone | 2件: Naloxone Naloxone; NALOXONE HYDROCHLORIDE; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 226 |
51 |
Nedaplatin
| - | 0件: | - | - | - |
52 |
Nifenazone
| - | 0件: | - | - | - |
53 |
Nandrolone cyclohexylpropionate
| - | 0件: | - | - | - |
54 |
Naftopidil
| - | 0件: | - | - | - |
55 |
Nandrolone furylpropionate
| - | 0件: | - | - | - |
56 |
Niceritrol
| - | 0件: | - | - | - |
57 |
Nicorandil
| - | 0件: | - | - | - |
58 |
Nilvadipine
| 1件: Nilvadipine Nilvadipine | 1件: Nilvadipine Nilvadipine; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
59 |
N-Methylscopolamine methylsulfate
| - | 0件: | - | - | - |
60 |
Naltrexone hydrochloride
| 1件: Naltrexone Naltrexone | 2件: Naltrexone Naltrexone; Naltrexone Hydrochloride; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
61 |
Nitric acid
| 1件: Nitrate Nitrate | 1件: Nitrate Nitrate; | - | - | 3件: 58 58, 113, 299 |
62 |
Nitazoxanide
| 1件: Nitazoxanide Nitazoxanide | 1件: Nitazoxanide Nitazoxanide; | - | - | 2件: 96 96, 97 |
63 |
Nifurpirinol
| - | 0件: | - | - | - |
64 |
Nicotine
| 1件: Nicotine Nicotine | 2件: Nicotine Nicotine; Nicotine gum; | 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 6 6, 13, 84 |
65 |
Nabilone
| 1件: Nabilone Nabilone | 1件: Nabilone Nabilone; | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 6 6, 13 |
66 |
Nagrestipen
| - | 0件: | - | - | - |
67 |
Nalmefene
| 1件: Nalmefene Nalmefene | 1件: Nalmefene Nalmefene; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
68 |
Naltrexone
| 1件: Naltrexone Naltrexone | 2件: Naltrexone Naltrexone; Naltrexone Hydrochloride; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
69 |
Nandrolone cyclotate
| - | 0件: | - | - | - |
70 |
Narasin
| - | 0件: | - | - | - |
71 |
Naxifylline
| - | 0件: | - | - | - |
72 |
Nebacumab
| - | 0件: | - | - | - |
73 |
Nebivolol
| 1件: Nebivolol Nebivolol | 1件: Nebivolol Nebivolol; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 17 17, 85, 113, 167 |
74 |
Nedocromil
| - | 0件: | - | - | - |
75 |
Nedocromil calcium
| - | 0件: | - | - | - |
76 |
Nelarabine
| - | 0件: | - | - | - |
77 |
Nepafenac
| - | 0件: | - | - | - |
78 |
Nequinate
| - | 0件: | - | - | - |
79 |
Nesiritide
| 1件: Nesiritide Nesiritide | 0件: | 1件: NPR1 NPR1 💬 | 10件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 46 46, 58 |
80 |
Netoglitazone
| - | 0件: | - | - | - |
81 |
Netupitant
| - | 0件: | - | - | - |
82 |
Nicotine bitartrate
| 1件: Nicotine Nicotine | 2件: Nicotine Nicotine; Nicotine gum; | 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 6 6, 13, 84 |
83 |
Nicotine polacrilex
| 1件: Nicotine Nicotine | 2件: Nicotine Nicotine; Nicotine gum; | 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 6 6, 13, 84 |
84 |
Nicotinyl alcohol
| - | 0件: | - | - | - |
85 |
Niridazole
| - | 0件: | - | - | - |
86 |
Nisoxetine
| - | 0件: | - | - | - |
87 |
Nitarsone
| - | 0件: | - | - | - |
88 |
Nitisinone
| 1件: Nitisinone Nitisinone | 2件: NITISINONE NITISINONE; Orfadin; | 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 3件: 6 6, 164, 241 |
89 |
Nocodazole
| - | 0件: | - | - | - |
90 |
Norelgestromin
| - | 0件: | - | - | - |
91 |
Norepinephrine bitartrate
| 1件: Norepinephrine Norepinephrine | 1件: Norepinephrine Norepinephrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 22 22 |
92 |
Norethynodrel
| - | 0件: | - | - | - |
93 |
Norflurane
| - | 0件: | - | - | - |
94 |
Norgestimate
| 1件: Norgestimate Norgestimate | 1件: Norgestimate Norgestimate; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 299 299 |
95 |
Norgestomet
| - | 0件: | - | - | - |
96 |
Nux vomica extract
| - | 0件: | - | - | - |
97 |
Natalizumab
| 1件: Natalizumab Natalizumab | 2件: Natalizumab Natalizumab; Tysabri; | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 6件: 13 13, 15, 25, 46, 63, 96 |
98 |
Niperotidine
| - | 0件: | - | - | - |
99 |
Nifuroxazide
| - | 0件: | - | - | - |
100 |
Norethandrolone
| - | 0件: | - | - | - |
101 |
Nicofuranose
| - | 0件: | - | - | - |
102 |
Norgestrienone
| - | 0件: | - | - | - |
103 |
Nomegestrol
| 1件: Nomegestrol Nomegestrol | 1件: Nomegestrol Nomegestrol; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
104 |
Nifurtoinol
| - | 0件: | - | - | - |
105 |
Nitroxoline
| - | 0件: | - | - | - |
106 |
Nifurzide
| - | 0件: | - | - | - |
107 |
Nicomorphine
| - | 0件: | - | - | - |
108 |
Niaprazine
| - | 0件: | - | - | - |
109 |
Nialamide
| - | 0件: | - | - | - |
110 |
Nimorazole
| - | 0件: | - | - | - |
111 |
Neltenexine
| - | 0件: | - | - | - |
112 |
Normethadone
| - | 0件: | - | - | - |
113 |
Nepinalone
| - | 0件: | - | - | - |
114 |
Nikethamide
| - | 0件: | - | - | - |
115 |
Noxytiolin
| - | 0件: | - | - | - |
116 |
Nafamostat
| - | 0件: | - | - | - |
117 |
Nafarelin
| - | 0件: | - | - | - |
118 |
Nafcillin
| - | 0件: | - | - | - |
119 |
Naftazone
| - | 0件: | - | - | - |
120 |
Naftidrofuryl
| - | 0件: | - | - | - |
121 |
Naftifine
| - | 0件: | - | - | - |
122 |
Nalbuphine
| 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine Nalbuphine; NALBUPHINE HYDROCHLORIDE; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
123 |
Nalorphine
| - | 0件: | - | - | - |
124 |
Naloxone
| 1件: Naloxone Naloxone | 2件: Naloxone Naloxone; NALOXONE HYDROCHLORIDE; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 226 |
125 |
Nandrolone
| 1件: Nandrolone Nandrolone | 1件: Nandrolone Nandrolone; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 60 60, 85 |
126 |
Naphazoline
| - | 0件: | - | - | - |
127 |
Naratriptan
| - | 0件: | - | - | - |
128 |
Nefazodone
| - | 0件: | - | - | - |
129 |
Nefopam
| - | 0件: | - | - | - |
130 |
Nelfinavir
| 1件: Nelfinavir Nelfinavir | 1件: Nelfinavir Nelfinavir; | - | - | 3件: 49 49, 265, 331 |
131 |
Neomycin
| 1件: Neomycin Neomycin | 1件: Neomycin Neomycin; | - | - | 3件: 96 96, 97, 296 |
132 |
Neostigmine
| 1件: Neostigmine Neostigmine | 1件: Neostigmine Neostigmine; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 11 11 |
133 |
Netilmicin
| - | 0件: | - | - | - |
134 |
Nicardipine
| 1件: Nicardipine Nicardipine | 1件: Nicardipine Nicardipine; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 70 70, 86 |
135 |
Niflumic acid
| - | 0件: | - | - | - |
136 |
Nimustine
| - | 0件: | - | - | - |
137 |
Nizofenone
| - | 0件: | - | - | - |
138 |
Nomegestrol acetate
| 1件: Nomegestrol acetate Nomegestrol acetate | 1件: Nomegestrol acetate Nomegestrol acetate; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
139 |
Nonivamide
| - | 0件: | - | - | - |
140 |
Nordazepam
| - | 0件: | - | - | - |
141 |
Norfenefrine
| - | 0件: | - | - | - |
142 |
Nortriptyline
| 1件: Nortriptyline Nortriptyline | 2件: Nortriptyline Nortriptyline; Nortriptyline hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 |
143 |
Naveglitazar
| - | 0件: | - | - | - |
144 |
Neratinib
| - | 0件: | - | - | - |
145 |
Nesbuvir
| - | 0件: | - | - | - |
146 |
Nilotinib
| 1件: Nilotinib Nilotinib | 2件: Nilotinib Nilotinib; TASIGNA; | 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 6 6, 8, 34, 51, 86 |
147 |
Nutmeg
| - | 0件: | - | - | - |
148 |
Nabiximols
| 1件: Nabiximols Nabiximols | 1件: Nabiximols Nabiximols; | - | - | 1件: 13 13 |
149 |
Naluzotan
| - | 0件: | - | - | - |
150 |
Naproxcinod
| - | 0件: | - | - | - |
151 |
Narlaprevir
| - | 0件: | - | - | - |
152 |
Nelotanserin
| 1件: Nelotanserin Nelotanserin | 1件: Nelotanserin Nelotanserin; | 1件: HTR2A HTR2A 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
153 |
Naronapride
| - | 0件: | - | - | - |
154 |
Navitoclax
| - | 0件: | - | - | - |
155 |
Nivocasan
| - | 0件: | - | - | - |
156 |
Naproxen etemesil
| - | 0件: | - | - | - |
157 |
Necitumumab
| - | 0件: | - | - | - |
158 |
Narnatumab
| - | 0件: | - | - | - |
159 |
Navarixin
| - | 0件: | - | - | - |
160 |
Niraparib
| - | 0件: | - | - | - |
161 |
Naldemedine
| - | 0件: | - | - | - |
162 |
Nivolumab
| 1件: Nivolumab Nivolumab | 1件: Nivolumab Nivolumab; | 1件: PDCD1 PDCD1 💬 | 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 |
163 |
Nelipepimut-S
| - | 0件: | - | - | - |
164 |
Nesvacumab
| - | 0件: | - | - | - |
165 |
Naloxegol
| - | 0件: | - | - | - |
166 |
Nintedanib
| 1件: Nintedanib Nintedanib | 2件: NINTEDANIB NINTEDANIB; Ofev; | 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | 34件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 5件: 51 51, 85, 89, 227, 228 |
167 |
Napabucasin
| - | 0件: | - | - | - |
168 |
Nonacog beta pegol
| - | 0件: | - | - | - |
169 |
Nusinersen
| 1件: Nusinersen Nusinersen | 2件: NUSINERSEN NUSINERSEN; Spinraza; | 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
170 |
Naquotinib
| - | 0件: | - | - | - |
171 |
Neflamapimod
| 1件: Neflamapimod Neflamapimod | 1件: Neflamapimod Neflamapimod; | 4件: MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 1件: 8 8 |
172 |
Nirogacestat
| - | 0件: | - | - | - |
173 |
Netarsudil
| - | 0件: | - | - | - |
174 |
Nemolizumab
| 1件: Nemolizumab Nemolizumab | 1件: Nemolizumab Nemolizumab; | 1件: IL31RA IL31RA 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 51 51 |
175 |
Navicixizumab
| - | 0件: | - | - | - |
176 |
Navoximod
| - | 0件: | - | - | - |
177 |
Nemiralisib
| - | 0件: | - | - | - |
178 |
Nevanimibe
| 1件: Nevanimibe Nevanimibe | 1件: Nevanimibe Nevanimibe; | - | - | 2件: 75 75, 81 |
179 |
Nacubactam
| - | 0件: | - | - | - |
180 |
Nirsevimab
| - | 0件: | - | - | - |
181 |
Naxitamab
| - | 0件: | - | - | - |
182 |
Nazartinib
| - | 0件: | - | - | - |
183 |
Nimacimab
| - | 0件: | - | - | - |
184 |
Nanatinostat
| - | 0件: | - | - | - |
185 |
Nomacopan
| 1件: Nomacopan Nomacopan | 2件: COVERSIN COVERSIN; NOMACOPAN; | 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 62 62, 109, 162 |
186 |
Narsoplimab
| 1件: Narsoplimab Narsoplimab | 2件: MASP-2 antibody MASP-2 antibody; Narsoplimab; | 1件: MASP2 MASP2 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 4件: 64 64, 66, 109, 222 |
187 |
Nipocalimab
| 1件: Nipocalimab Nipocalimab | 1件: Nipocalimab Nipocalimab; | 1件: FCGRT FCGRT 💬 | - | 5件: 11 11, 46, 49, 53, 61 |
188 |
Necuparanib
| - | 0件: | - | - | - |
189 |
Nutmeg oil
| - | 0件: | - | - | - |
190 |
Nirmatrelvir
| - | 0件: | - | - | - |